search
Company Information
USD
12.29
- (2.2%)
NASDAQ:VRDN, VIRIDIAN THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 7 May 2025 GMT-4
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Address

221 Crescent Street
Suite 401

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Dr. Thomas Ciulla
Chief Medical Officer
Ms. Arlene M. Morris
Director
Ms. Jennifer K. Moses
Director
Mr. Thomas W. Beetham
COO
Mr. Stephen Mahoney
CEO/Director/President
Mr. Peter Harwin
Director
Mr. Tomas Kiselak
Chairman of the Board/Director
Dr. Sarah Gheuens
Director
Mr. Seth Harmon
CFO/Chief Accounting Officer/Senior VP, Divisional
Ms. Lara Meisner
Chief Legal Officer

Ownership

Institution Holdings

FMR Inc
7,625,542 (12.149%)
FMR LLC
7,625,542 (12.149%)
Paradigm Biocapital Advisors LP
4,794,488 (7.638%)
Fidelity SelectCo, LLC
4,463,715 (7.112%)
Deep Track Capital, LP
3,631,728 (5.786%)
Fidelity Management & Research Company LLC
3,586,749 (5.714%)
BlackRock Inc
3,426,450 (5.459%)
VR Adviser, LLC
3,082,622 (4.911%)
Vanguard Group Inc
3,000,948 (4.781%)
State Street Corporation
2,708,383 (4.315%)

Funds Holdings

SPDR® S&P Biotech ETF
1,901,465 (3.029%)
Vanguard US Total Market Shares ETF
1,782,389 (2.840%)
Vanguard Total Stock Market Index Fund
1,782,389 (2.840%)
Fidelity Advisor Biotechnology Fund
1,284,907 (2.047%)
Fidelity Select Health Care Portfolio
1,180,000 (1.880%)
iShares Russell 2000 ETF
1,058,222 (1.686%)
AB Small Cap Growth Portfolio
957,805 (1.526%)
Polar Capital Biotechnology Fund
910,719 (1.451%)
Vanguard Institutional Extnd Mkt Idx Tr
817,369 (1.302%)
Fidelity Advisor Health Care Fund
750,000 (1.195%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices